Literature DB >> 10506122

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

K T Jeang1, H Xiao, E A Rich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10506122     DOI： 10.1074/jbc.274.41.28837

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  154 in total

1.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Tat-neutralizing antibodies in vaccinated macaques.

Authors:  Ilia Tikhonov; Tracy J Ruckwardt; Glen S Hatfield; C David Pauza
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  A nucleolar TAR decoy inhibitor of HIV-1 replication.

Authors:  Alessandro Michienzi; Shirley Li; John A Zaia; John J Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

4.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.

Authors:  H Xiao; C Neuveut; H L Tiffany; M Benkirane; E A Rich; P M Murphy; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription.

Authors:  Fabien Darfeuille; Andrey Arzumanov; Sergei Gryaznov; Michael J Gait; Carmelo Di Primo; Jean-Jacques Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-08       Impact factor: 11.205

6.  Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine.

Authors:  Udaykumar Ranga; Raj Shankarappa; Nagadenahalli B Siddappa; Lakshmi Ramakrishna; Ramalingam Nagendran; Marthandan Mahalingam; Anita Mahadevan; Narayana Jayasuryan; Parthasarathy Satishchandra; Susarla K Shankar; Vinayaka R Prasad
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Genetic characterization of HIV type 1 Tat exon 1 from a southern Indian clinical cohort: identification of unique epidemiological signature residues.

Authors:  Ujjwal Neogi; Soham Gupta; Pravat Nalini Sahoo; Anita Shet; Shwetha D Rao; Udaykumar Ranga; Vinayaka R Prasad
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-02       Impact factor: 2.205

8.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

9.  Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking.

Authors:  Raffaella Pierleoni; Michele Menotta; Antonella Antonelli; Carla Sfara; Giordano Serafini; Sabrina Dominici; Maria Elena Laguardia; Annalisa Salis; Gianluca Damonte; Lucia Banci; Marco Porcu; Paolo Monini; Barbara Ensoli; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2010-08-20       Impact factor: 3.396

10.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.